Brief: India's Jubilant Pharmova Posts Dec-Quarter Consol Loss Vs Profit
Feb 3 (Reuters) - Jubilant Pharmova Ltd JUBA.NS :
* DEC-QUARTER CONSOL NET LOSS 156.7 MILLION RUPEES VERSUS
PROFIT
509.9 MILLION RUPEES
* DEC-QUARTER CONSOL SALES 1.53 BILLION RUPEES VERSUS 1.30
BILLION
RUPEES
* IN FY24, PROFITABILITY EXPECTED TO IMPROVE DRIVEN BY
RADIOPHARMACEUTICALS, ALLERGY IMMUNOTHERAPY, CDMO STERILE
INJECTABLES
* CAPEX PLAN UNDERWAY FOR ADDITIONAL BUILDING BLOCK IN
GREATER
NOIDA FACILITY
Source text for Eikon: ID:nNSE5djR5R
Further company coverage: JUBA.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures